Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

13 trials with published results (16%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.9%

4 terminated out of 81 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

11%

9 trials in Phase 3/4

Results Transparency

30%

13 of 44 completed with results

Key Signals

13 with results92% success

Data Visualizations

Phase Distribution

53Total
Not Applicable (26)
P 1 (3)
P 2 (15)
P 3 (4)
P 4 (5)

Trial Status

Completed44
Unknown15
Recruiting12
Terminated4
Not Yet Recruiting3
Active Not Recruiting2

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 44 completed trials

Clinical Trials (81)

Showing 20 of 20 trials
NCT01005654Recruiting

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

NCT06638931Phase 2Recruiting

Agnostic Therapy in Rare Solid Tumors

NCT06220656Not ApplicableRecruiting

TRAIL Study: Feasibility and Pilot

NCT03573960Phase 4CompletedPrimary

A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer

NCT07447089Not ApplicableRecruitingPrimary

EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study

NCT07434206Phase 2Active Not RecruitingPrimary

Safety and Efficacy of Dexmedetomidine in Controlling Hemodynamics During Resection of Active Thyroid Secreting Tumors

NCT07419932Recruiting

Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer

NCT06853925Not ApplicableRecruitingPrimary

Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients

NCT03160274Recruiting

Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions

NCT05241834Phase 1Active Not Recruiting

A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment

NCT05022667Not ApplicableCompletedPrimary

Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy

NCT05579782Not ApplicableCompleted

Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy

NCT07033572Not ApplicableRecruitingPrimary

Hybrid Endoscopic Hemithyroidectomy and Targeted Ablation for Bilateral Papillary Thyroid Carcinoma

NCT07042984Not Yet Recruiting

RET-US Study - Ultrasound-Based Prediction of RET Alterations and Lateral-Neck Metastasis in Thyroid Cancer

NCT07042971Not ApplicableNot Yet Recruiting

Peri-operative BiPAP to Prevent Tracheostomy in High-Risk Bilateral Vocal-Cord Paralysis (BVCP)

NCT07010380RecruitingPrimary

Dual-Channel Near-Infrared Autofluorescence Imaging and AI Analysis to Locate Parathyroid Glands (PTFinder)

NCT07010393Phase 4Not Yet RecruitingPrimary

Genotype-Driven Neoadjuvant Therapy for Locally Advanced Thyroid Cancer: A Real-World Cohort Study

NCT04420689Phase 1Completed

Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery

NCT04139096CompletedPrimary

Genetic Susceptibility to Radiation Induced Thyroid Cancer

NCT06398795Not ApplicableRecruitingPrimary

Dual-port Trans-subclavian Thyroid Endoscopic Surgery

Scroll to load more

Research Network

Activity Timeline